FdaApplication

NDA 212608

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBLUEPRINT MEDICINES CORP
application_typeNDA
approval_date2020-01-09

Products (5)

ProductActive ingredientStrengthDosage form
AYVAKITAVAPRITINIB50MGTABLET;ORAL
AYVAKITAVAPRITINIB25MGTABLET;ORAL
AYVAKITAVAPRITINIB200MGTABLET;ORAL
AYVAKITAVAPRITINIB100MGTABLET;ORAL
AYVAKITAVAPRITINIB300MGTABLET;ORAL

5 products